, and indicate that the use of this isotope in thyroid disease contributes only about 0-6% of the total exposure from medical radiology.
In the individual, thyroid irradiation will normally not exceed 10 rads when 5 pc test doses of 13ll are given to adults, but exposure five to ten times higher could occur in the glands of infants or foetuses, or in tests on non-goitrous children (Table 2 ).
In such cases the thyroid exposure can normally be reduced to below 1 rad by using 5 pc doses of 1321 if the necessary diagnostic informa- Halnan & Pochin (1958) but taking a 30% mean uptake in infants and normal children or 60 % in the goitrous child, and a possible ratio of from 2 to 5 between radioiodine concentrations per gram of feetal and maternal thyroid tion is obtainable by measurements that can be made during the first few hours after administration of this short-lived form of radioiodine.
Radiation exposures of the gonads, the marrow and the body tissues generally are much less than those of the thyroid -by a factor of the order of 100 in the case of 132I and of several hundreds for 1311. In the radioiodine therapy of hyperthyroidism, the mean dose to blood is likely to be between 15 and 20 rads, although substantially higher doses may occur in some patients (Green et al. 1961) . Despite the treatment of large numbers of patients, no evidence has been obtained of any excess incidence of leukemia above that which would be expected by chance (Pochin 1960) . Similarly, at least 20 cases of thyroid cancer should have occurred by chance alone in these patients, if treated hyperthyroid patients have a normal likelihood of developing this malignancy (Pochin 1964a) ; and no such number of cases has yet been reported. Hepatic irradiation during this treatment may occasionally be substantial, perhaps reaching 500 to 1,000 rads, owing to the Not so many years ago, the enthusiastic radiotherapist found it difficult to achieve tissuenecrosing doses at the centre of the abdomen. He was handicapped by the technical inferiority of his apparatus, the layer of adipose tissue provided so abundantly by nature in many patients and the tendency of the skin to protest by undergoing moist desquamation. Now the general availability of supervoltage apparatus has made possible, with some ease, high tissue doses at any point within the abdominal cavity.
Nowadays, for the most part, radiotherapy in a tissue dose of 5,000 r or above is used within the abdomen when the therapist is attempting to eradicate malignant disease, firstly within the pelvis, that is, in the treatment of the cervix or bladder, and secondly, in the prophylactic irradiation of teratoma of the testis.
Following lessons learnt the hard way when our 2 MeV Van de Graaff generator became available in 1950, we now try to restrict the use of opposing fields to the abdominal cavity whenever possible, particularly when it is intended to deliver a high dose.
Case 1
The patient shown in Fig 1 had a carcinoma Total maximum tumour dose 6,000 r; total minimum tumour dose 5,040 r; total maximum skin dose 6,240 r. Overall time 53 days. HVL 7-4 mm lead. FSD 100 cm. Progress: She experienced little disturbance during therapy apart from mild nausea and increasing frequency of micturition, but three months after completion of treatment, hematuria began to be a distressing feature. Cystoscopic examination at this stage revealed the characteristic radiation telangiectasis of the bladder mucosa.
On 16.12.54, one year after irradiation, the treatment fields both anteriorly and posteriorly were delineated by gross post-irradiation fibrosis, cedema, loss of subcutaneous fat and loss of elasticity. By April 1955, more than two years after therapy, the patient was being weakened by attacks of watery and mucoid diarrheea. At this stage, rectal and vaginal examination showed much fibrosis, narrowing and loss of elasticity of these structures.
This patient, though she was free from disease, suffered greatly from the delayed effects of irradiation delivered through an opposing field method. It is now nearly eleven years since she was treated and she still leaks urine at night.
It is still our practice to use opposing fields in prophylactic irradiation of testicular teratomata but then the field size and dosage aimed at takes into account the lessons learned, for the width of the field is restricted to 10 cm and the dose to the centre of the abdomen, is not allowed to exceed 4,750-5,000 r in five to five and a half weeks.
So far, after nine and a half years' experience, we have had, out of 68 cases, only 2 of long-lasting intestinal complications and there has been no evidence of damage to the spinal cord. The only untoward reaction, and this is not observed with any great frequency, is a relatively mild skin leathering in the treatment area. The improvement in our survival figures referring to those cases of teratoma of the testis presenting without clinical evidence of glandular or pulmonary metastases before and after the advent of supervoltage irradiation, bears testimony to the effectiveness of the more modern therapy. Up to 1954 67 cases in the above group were treated by conventional 250 kV irradiation giving a five-year survival
